These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25863416)

  • 1. Rare Incidence of Ventricular Tachycardia and Torsades de Pointes in Hospitalized Patients With Prolonged QT Who Later Received Levofloxacin: A Retrospective Study.
    Stancampiano FF; Palmer WC; Getz TW; Serra-Valentin NA; Sears SP; Seeger KM; Pagan RJ; Racho RG; Ray JC; Snipelisky DF; Mentel JJ; Diehl NN; Heckman MG
    Mayo Clin Proc; 2015 May; 90(5):606-12. PubMed ID: 25863416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.
    Brady WJ; DeBehnke DJ; Laundrie D
    Acad Emerg Med; 1999 Jun; 6(6):609-17. PubMed ID: 10386678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
    Ryan K; Benz P; Zosel A; Farkas A; Theobald J
    Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study.
    Sears SP; Getz TW; Austin CO; Palmer WC; Boyd EA; Stancampiano FF
    Drugs Real World Outcomes; 2016 Mar; 3(1):99-105. PubMed ID: 27747808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk screening for long QT prior to prescribing levofloxacin.
    Tsai LH; Weng YM; Lin CC; Kuo CW; Chen JC
    Am J Emerg Med; 2014 Sep; 32(9):1153.e1-3. PubMed ID: 24666739
    [No Abstract]   [Full Text] [Related]  

  • 7. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia.
    Shojaei L; Ruzbahani M; Khajavian S; Shahsavari S; Tamasoki N; Rajabian M; Moradi F; Shahbazi F
    Curr Drug Saf; 2020; 15(2):111-116. PubMed ID: 32053078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes caused by Mibefradil.
    Gläser S; Steinbach M; Opitz C; Wruck U; Kleber FX
    Eur J Heart Fail; 2001 Oct; 3(5):627-30. PubMed ID: 11595612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?
    Nuttall GA; Malone AM; Michels CA; Trudell LC; Renk TD; Marienau ME; Oliver WC; Ackerman MJ
    Anesthesiology; 2013 Feb; 118(2):382-6. PubMed ID: 23291623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
    Tilton JJ; Sadr R; Groo VL
    J Oncol Pharm Pract; 2019 Dec; 25(8):2004-2006. PubMed ID: 30501378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvolt T-wave alternans monitoring in a patient with levofloxacin-induced Torsade de Pointes.
    Sahashi Y; Takasugi N; Naruse G; Kubota T; Nishigaki K; Minatoguchi S
    J Electrocardiol; 2018; 51(1):108-110. PubMed ID: 29126547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
    Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin induced polymorphic ventricular tachycardia with normal QT interval.
    Paltoo B; O'Donoghue S; Mousavi MS
    Pacing Clin Electrophysiol; 2001 May; 24(5):895-7. PubMed ID: 11388112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [QTc-prolonging drugs and the risk of sudden death].
    Reingardiene D; Vilcinskaite J
    Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
    Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
    Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients.
    Girgis I; Gualberti J; Langan L; Malek S; Mustaciuolo V; Costantino T; McGinn TG
    Chest; 1997 Sep; 112(3):646-53. PubMed ID: 9315796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
    Uvelin A; Pejaković J; Mijatović V
    J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.